Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1107 of 5804
-
Can video Game-Style PE get kids moving more?
Disease control CompletedThis study evaluates the effects of an 8-week gamified cooperative exergaming program implemented during regular physical education lessons in primary school children. Participants were assigned by classroom to either an experimental group, which completed "The Movement League" p…
Phase: NA • Sponsor: University of Jaén • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for teens with painful skin condition: experimental drug povorcitinib under study
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Common antibiotic could boost stroke recovery in major new trial
Disease control Recruiting nowThe goal of this study is to determine if Minocycline, when added to standard care, can improve survival and functional outcomes in patients with moderate acute stroke (ischemic or hemorrhagic) aged 18 years and older. The main questions it aims to answer are: 1. Does Minocycli…
Phase: PHASE2, PHASE3 • Sponsor: Joyce Chen • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
5,000 volunteers tracked to see if chikungunya vaccine is safe
⭐️ VACCINE ⭐️ OngoingThis is an observational study with primary data collection, which will combine a prospective safety cohort study and an SCRI study.
Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
New pill combo aims to ease stubborn shingles nerve pain
Symptom relief Recruiting nowThe goal of this clinical trial is to assess the efficacy and safety of Y-4 in patients with postherpetic neuralgia(PHN). The main questions it aims to answer are: The efficacy and safety of Y-4 to treat PHN compared with pregabalin. Researchers will analyze data from different…
Phase: PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New radiation boost aims to zap prostate tumors harder, faster
Disease control Recruiting nowThis study is for adult men with previously untreated high risk, very high risk, or pelvic lymph node positive prostate cancer. The purpose of this study is to evaluate the safety and effectiveness of the combination of two emerging radiation treatment techniques (hypofractionate…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New biologic GR1803 aims to tame lupus in early trial
Disease control Recruiting nowto evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brazilian pilot program tests chikungunya Vaccine's Real-World power
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis is an observational, non-interventional, test-negative case-control (TNCC) study to estimate the vaccine effectiveness of VLA1553 against Chikungunya virus in a real-world setting.
Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
New hope for muscle disease: drug trial launches
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy of Telitacicept in the treatment of inflammatory myopathy in patients with inflammatory diseases. The main question it aims to answer is: the safety and effectiveness of Telitacicept in treating inflammatory myopathy.
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for advanced lung cancer patients with no options left
Disease control Recruiting nowThe present study will explore a novel treatment strategy for unresectable lung adenocarcinoma combining a unique unconventional radiotherapy technique for high dose partial tumor irradiation (PTI) sparing the peritumoral immune microenvironment (PIM) with an immune checkpoint in…
Phase: NA • Sponsor: Karl Landsteiner University of Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a mitochondrial peptide help reverse prediabetes?
Disease control Recruiting nowThis Phase 2a study evaluates whether 12 weeks of treatment with investigational MOTS-c improves insulin sensitivity compared with placebo in adults with prediabetes and overweight/obesity. Participants are randomized 1:1 to MOTS-c or placebo, receive standardized lifestyle coun…
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Playtime against bullying: could drama and games curb peer cruelty?
Prevention CompletedThis randomized controlled trial evaluated the effectiveness of the Renkli Adımlar (Colorful Steps) game- and drama-based school intervention in promoting empathy and reducing bullying perpetration and victimization among primary school children. Third- and fourth-grade students …
Phase: NA • Sponsor: Burdur Mehmet Akif Ersoy University • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New pump may bring comfort to Parkinson's patients in final days
Symptom relief Recruiting nowCare for Parkinson's patients at the end of life is far from optimal, particularly due to specificities linked to the disease itself, often unknown to non-specialists. A study carried out at the CHU Rennes on data covering the period 2006-2018 showed that only 132 patients died …
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Heated chemo after surgery shows promise for rare chest cancer spread
Disease control Not yet recruitingThe goal of this observational study is to explore the effectiveness of electrocautery resection combined with hyperthermic intrathoracic chemotherapy (HITHOC) in patients with thymic epithelial tumors with pleural metastasis or recurrence. The study aims to: * Evaluate whether …
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to shrink Hard-to-Treat throat cancer
Disease control Not yet recruitingThis study aims to explore the efficacy and safety of scipibaimab combined with tislelizumab in patients with recurrent or metastatic nasopharyngeal carcinoma who have progressed after first-line therapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New blood test could speed up TB diagnosis
Diagnosis Recruiting nowTuberculosis (TB) is one of the leading causes of infectious disease worldwide. The diagnosis of TB typically relies on microbiological evidence of the presence of Mycobacterium tuberculosis (MTB) or histological features of the host immune response to MTB in the infected organs.…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Double attack on tumors: freeze then irradiate shows promise in early trial
Disease control Not yet recruitingThis open-label, randomized Phase II trial evaluates whether sequential iodine-125 seed implantation followed by cryoablation improves local tumor control versus single-modality local therapy (125I seeds alone or cryoablation alone) in unresectable solid tumors. The study is bas…
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New lens design aims to halt worsening eyesight in children
Disease control ENROLLING_BY_INVITATIONEvaluate the effectiveness of different lithographic microstructured myopia management lenses in controlling the progression of myopia in children and adolescents, as well as the safety and comfort of wearing them. Explore effective defocus microlens designs for myopia control an…
Phase: NA • Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Mindfulness may ease emotional and physical toll of bullying in teens
Symptom relief OngoingThis study examines the psychosocial correlates of trait emotional intelligence and psychosomatic symptoms among adolescents exposed to bullying and analyzes the effetiveness of Mindfulness Based Stress Reduction (MBSR) program through a randomized controlled trial. The study is…
Phase: NA • Sponsor: Fatima Jinnah Women University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New eczema drug GS101 takes on dupixent in major trial
Disease control Not yet recruitingThis is a a multicenter, randomized, double-blinded, parallel, positive-controlled, Phase III comparative study to evaluate GS101 Injection versus Dupixent® in participants with moderate-to-severe atopic dermatitis. A total of 572 subjects are planned to be included and randomize…
Phase: PHASE3 • Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC